| scholarly article | Q13442814 |
| P50 | author | Kenneth K. Teng | Q37378083 |
| P2093 | author name string | Barbara L Hempstead | |
| Zhe-Yu Chen | |||
| Francis S Lee | |||
| Paresh D Patel | |||
| Chui-Xiang Meng | |||
| Gayatree Sant | |||
| P2860 | cites work | Neurotrophins: roles in neuronal development and function | Q24656166 |
| Regulation of cell survival by secreted proneurotrophins | Q27919620 | ||
| The granin (chromogranin/secretogranin) family | Q28284590 | ||
| ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury | Q28574864 | ||
| The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
| Neurotrophins and their receptors: a convergence point for many signalling pathways | Q29616108 | ||
| BDNF and activity-dependent synaptic modulation | Q33820669 | ||
| Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder | Q33905209 | ||
| Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor | Q33932396 | ||
| Activation of Trk neurotrophin receptors in the absence of neurotrophins | Q33937877 | ||
| Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors | Q34028643 | ||
| Neurotrophins as synaptic modulators | Q34186265 | ||
| The granin family--its role in sorting and secretory granule formation | Q34399146 | ||
| Storage and release of acetylcholine by a clonal cell line | Q35062636 | ||
| Pro-region of neurotrophins: role in synaptic modulation | Q35209102 | ||
| p75(NTR) mediates neurotrophin-induced apoptosis of vascular smooth muscle cells | Q35745844 | ||
| Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury | Q35796028 | ||
| The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. | Q37219127 | ||
| Neurotrophin-4, alone or heterodimerized with brain-derived neurotrophic factor, is sorted to the constitutive secretory pathway | Q40635192 | ||
| Sorting and processing of secretory proteins | Q40744676 | ||
| Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor | Q40832311 | ||
| Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. | Q41142309 | ||
| The regulated secretion and vectorial targeting of neurotrophins in neuroendocrine and epithelial cells | Q41159160 | ||
| The biosynthesis of neurotrophin heterodimers by transfected mammalian cells | Q41344531 | ||
| Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation | Q41596156 | ||
| A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression | Q42694857 | ||
| Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons | Q43435250 | ||
| Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus | Q43450226 | ||
| Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms | Q43849066 | ||
| Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor | Q44078822 | ||
| Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. | Q44531022 | ||
| Coexpression of mRNAs for NGF, BDNF, and NT-3 in the cardiovascular system of the pre- and postnatal rat. | Q45942456 | ||
| Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. | Q47724311 | ||
| Pleiotropic functions of neurotrophins in development. | Q52184080 | ||
| Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. | Q53246711 | ||
| Neurotrophin-3 sorts to the constitutive secretory pathway of hippocampal neurons and is diverted to the regulated secretory pathway by coexpression with brain-derived neurotrophic factor | Q57042409 | ||
| Selective role for trkB neurotrophin receptors in rapid modulation of hippocampal synaptic transmission | Q71501957 | ||
| Expression of mRNAs for neurotrophins and their receptors in developing rat heart | Q71720426 | ||
| Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization | Q73053921 | ||
| NGF activates similar intracellular signaling pathways in vascular smooth muscle cells as PDGF-BB but elicits different biological responses | Q77297677 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rs6265 | Q7375573 |
| P304 | page(s) | 4401-4411 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons | |
| P478 | volume | 24 |
| Q37054137 | A Case-Control Study and Meta-Analysis Reveal BDNF Val66Met Is a Possible Risk Factor for PTSD. |
| Q64093272 | A Novel Peptide Interfering with proBDNF-Sortilin Interaction Alleviates Chronic Inflammatory Pain |
| Q48292334 | A brain-derived neurotrophic factor polymorphism Val66Met identifies fibromyalgia syndrome subgroup with higher body mass index and C-reactive protein |
| Q48182219 | A genotype-endophenotype-phenotype path model of depressed mood: integrating cognitive and emotional markers |
| Q35049949 | A neurogenetics approach to defining differential susceptibility to institutional care |
| Q34612732 | A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques |
| Q34148214 | A novel endocytic recycling signal distinguishes biological responses of Trk neurotrophin receptors |
| Q35844099 | A review on experimental and clinical genetic associations studies on fear conditioning, extinction and cognitive-behavioral treatment |
| Q90248276 | A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia |
| Q42089818 | A sexually dimorphic pre-stressed translational signature in CA3 pyramidal neurons of BDNF Val66Met mice |
| Q34099252 | A simple role for BDNF in learning and memory? |
| Q34344423 | A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume--a genuine effect or a winners curse? |
| Q45896767 | Acquisition and generalization of fear conditioning are not modulated by the BDNF-val66met polymorphism in humans |
| Q36637069 | Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF) |
| Q46604995 | Activation of p75NTR by proBDNF facilitates hippocampal long-term depression |
| Q37373464 | Activity-dependent dendritic release of BDNF and biological consequences. |
| Q50584031 | Adenosine A1 Receptors Play an Important Protective Role Against Cognitive Impairment and Long-Term Potentiation Inhibition in a Pentylenetetrazol Mouse Model of Epilepsy. |
| Q47262957 | Adolescent Corticosterone and TrkB Pharmaco-Manipulations Sex-Dependently Impact Instrumental Reversal Learning Later in Life |
| Q37245271 | Allelic distribution of BDNF Val66Met polymorphism in healthy Romanian volunteers. |
| Q37465593 | Altered Episodic Memory in Introverted Young Adults Carrying the BDNFMet Allele |
| Q30477199 | Amygdala-dependent fear conditioning in humans is modulated by the BDNFval66met polymorphism. |
| Q45917874 | An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. |
| Q35034804 | Analyzing the influence of BDNF heterozygosity on spatial memory response to 17β-estradiol |
| Q45922559 | Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in Borderline personality disorder. |
| Q48473268 | Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease |
| Q36528457 | Association between BDNF rs6265 and obesity in the Boston Puerto Rican Health Study |
| Q48958164 | Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population |
| Q35225338 | Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease. |
| Q34085837 | Association between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence |
| Q46840112 | Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease |
| Q34706991 | Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia |
| Q47909466 | Association between genes, stressful childhood events and processing bias in depression vulnerable individuals |
| Q60620014 | Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients |
| Q50061520 | Association of BDNF Val66Met Polymorphism and Brain BDNF levels with Major Depression and Suicide |
| Q34523157 | Association of BDNF Val66Met polymorphism with HPA and SAM axis reactivity to psychological and physical stress |
| Q90013519 | Association of BDNF rs6265 and MC4R rs17782313 with metabolic syndrome in Pakistanis |
| Q42927243 | Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population |
| Q35186571 | Association of functional polymorphisms from brain-derived neurotrophic factor and serotonin-related genes with depressive symptoms after a medical stressor in older adults |
| Q49025094 | Association of the BDNF Val66Met variation with obesity in women. |
| Q51034231 | Attention-deficit hyperactivity disorder and intellectual disability: a study of association with brain-derived neurotrophic factor gene polymorphisms. |
| Q64085334 | BDNF Actions in the Cardiovascular System: Roles in Development, Adulthood and Response to Injury |
| Q36906438 | BDNF Genotype Interacts with Motor Function to Influence Rehabilitation Responsiveness Poststroke |
| Q37310834 | BDNF Val(66)Met Polymorphism Influences Visuomotor Associative Learning and the Sensitivity to Action Observation |
| Q35987786 | BDNF Val(66)Met genotype is associated with drug-seeking phenotypes in heroin-dependent individuals: a pilot study |
| Q91583675 | BDNF Val66Met Genetic Polymorphism Results in Poor Recovery Following Repeated Mild Traumatic Brain Injury in a Mouse Model and Treatment With AAV-BDNF Improves Outcomes |
| Q35931426 | BDNF Val66Met Polymorphism Is Associated with Self-Reported Empathy. |
| Q92537291 | BDNF Val66Met Positive Players Demonstrate Diffusion Tensor Imaging Consistent With Impaired Myelination Associated With High Levels of Soccer Heading: Indication of a Potential Gene-Environment Interaction Mechanism |
| Q35713564 | BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association |
| Q34233144 | BDNF Val66Met genotype and 6-month remission rates in late-life depression |
| Q35837743 | BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity |
| Q61651981 | BDNF Val66Met polymorphism and brain volumes in multiple sclerosis |
| Q57160899 | BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis |
| Q33530233 | BDNF Val66Met polymorphism and protein levels in amniotic fluid |
| Q36405986 | BDNF Val66Met polymorphism interacts with sex to influence bimanual motor control in healthy humans |
| Q33614257 | BDNF Val66Met polymorphism, energy intake and BMI: a follow-up study in schoolchildren at risk of eating disorders |
| Q38625092 | BDNF Val66Met variant and age of onset in schizophrenia. |
| Q34535122 | BDNF Val66Met variant and smoking in a Chinese population |
| Q48024639 | BDNF and LTP-/LTD-like plasticity of the primary motor cortex in Gilles de la Tourette syndrome |
| Q43802974 | BDNF contributes to the facilitation of hippocampal synaptic plasticity and learning enabled by environmental enrichment |
| Q36950532 | BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity. |
| Q37450600 | BDNF genotype modulates resting functional connectivity in children |
| Q38831821 | BDNF isoforms: a round trip ticket between neurogenesis and serotonin? |
| Q34115242 | BDNF modulates contextual fear learning during adolescence |
| Q64819678 | BDNF provides many routes toward STN DBS-mediated disease modification |
| Q35203597 | BDNF release is required for the behavioral actions of ketamine |
| Q38166455 | BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis |
| Q57799313 | BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression |
| Q37602560 | BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. |
| Q42517523 | BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors. |
| Q35844321 | BDNF val66met affects hippocampal volume and emotion-related hippocampal memory activity |
| Q33992471 | BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression |
| Q33733000 | BDNF variant Val66Met interacts with estrous cycle in the control of hippocampal function |
| Q33854887 | BDNF variants, premorbid educational attainment, and disease characteristics in Alzheimer's disease: an exploratory study |
| Q42475620 | BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects |
| Q47958150 | BDNF, relative preference, and reward circuitry responses to emotional communication |
| Q36589545 | BDNF-TrkB signaling and neuroprotection in schizophrenia |
| Q38670024 | BDNF: A Key Factor with Multipotent Impact on Brain Signaling and Synaptic Plasticity. |
| Q48322989 | Biology trumps statistics in the postgenomic era. |
| Q34364063 | Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology |
| Q34110230 | Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. |
| Q24647109 | Brain foods: the effects of nutrients on brain function |
| Q37594329 | Brain plasticity and genetic factors |
| Q36279804 | Brain-Derived Neurotrophic Factor (BDNF) in Traumatic Brain Injury-Related Mortality: Interrelationships Between Genetics and Acute Systemic and Central Nervous System BDNF Profiles |
| Q41769724 | Brain-Derived Neurotrophic Factor (Val66Met) and Serotonin Transporter (5-HTTLPR) Polymorphisms Modulate Plasticity in Inhibitory Control Performance Over Time but Independent of Inhibitory Control Training |
| Q48099455 | Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies |
| Q33619386 | Brain-Derived Neurotrophic Factor Val66Met Gene Polymorphism Impacts on Migraine Susceptibility: A Meta-analysis of Case-Control Studies |
| Q39896459 | Brain-Derived Neurotrophic Factor Val66Met Polymorphism Affects the Relationship Between an Anxiety-Related Personality Trait and Resting Regional Cerebral Blood Flow |
| Q41452493 | Brain-Derived Neurotrophic Factor, Depression, and Physical Activity: Making the Neuroplastic Connection. |
| Q26795382 | Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions |
| Q37113505 | Brain-derived neurotrophic factor (Val66Met) polymorphism and olfactory ability in young adults |
| Q36349176 | Brain-derived neurotrophic factor Val(66)Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study |
| Q34061150 | Brain-derived neurotrophic factor Val66Met allele impairs basal and ketamine-stimulated synaptogenesis in prefrontal cortex |
| Q38564467 | Brain-derived neurotrophic factor Val66Met polymorphism, human memory, and synaptic neuroplasticity. |
| Q35995934 | Brain-derived neurotrophic factor Val⁶⁶Met polymorphism affects resting regional cerebral blood flow and functional connectivity differentially in women versus men |
| Q37003649 | Brain-derived neurotrophic factor and suicide pathogenesis |
| Q45984035 | Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression. |
| Q48536488 | Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder |
| Q34075816 | Brain-derived neurotrophic factor genotype is associated with brain gray and white matter tissue volumes recovery in abstinent alcohol-dependent individuals |
| Q34815106 | Brain-derived neurotrophic factor in chronic periodontitis. |
| Q98733449 | Brain-derived neurotrophic factor polymorphism Val66Met protects against cancer-related fatigue |
| Q52647021 | Brain-derived neurotrophic factor secreted by the cerebral endothelium: A new actor of brain function? |
| Q24647110 | Brain-derived neurotrophic factor: role in depression and suicide |
| Q51875231 | Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology. |
| Q36047812 | Bridging animal and human models of exercise-induced brain plasticity |
| Q22252698 | Candidate gene studies of ADHD: a meta-analytic review |
| Q34987347 | Cell biology of BDNF and its relevance to schizophrenia |
| Q39663375 | Characterization of the intracellular localization, processing, and secretion of two glial cell line-derived neurotrophic factor splice isoforms. |
| Q26824841 | Charcot-Marie-Tooth disease and intracellular traffic |
| Q48258812 | Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein |
| Q38936602 | Clinical and genetic factors associated with suicide in mood disorder patients |
| Q49709684 | Cognition, serum BDNF levels, and BDNF Val66Met polymorphism in type 2 diabetes patients and healthy controls |
| Q34726039 | Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers |
| Q36900676 | Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls. |
| Q92615784 | Conditioned taste aversion memory extinction temporally induces insular cortical BDNF release and inhibits neuronal apoptosis |
| Q34410506 | Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent |
| Q38112245 | DNA methylation of the BDNF gene and its relevance to psychiatric disorders |
| Q45210021 | Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. |
| Q34588289 | Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases. |
| Q34159085 | Dendritic spine dysgenesis in Rett syndrome. |
| Q34630493 | Dendritic trafficking of brain-derived neurotrophic factor mRNA: regulation by translin-dependent and -independent mechanisms |
| Q48066589 | Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception. |
| Q24814359 | Difference in trafficking of brain-derived neurotrophic factor between axons and dendrites of cortical neurons, revealed by live-cell imaging |
| Q57892206 | Differential effects of pro-BDNF on sensory neurons after sciatic nerve transection in neonatal rats |
| Q48332729 | Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? |
| Q38649157 | Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders? |
| Q50860874 | Dosage effects of BDNF Val66Met polymorphism on cortical surface area and functional connectivity. |
| Q47890256 | Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression |
| Q34295880 | Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors |
| Q37171338 | Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects |
| Q47287966 | Effect of Early-Life Fluoxetine on Anxiety-Like Behaviors in BDNF Val66Met Mice |
| Q37388278 | Effect of childhood maltreatment and brain-derived neurotrophic factor on brain morphology |
| Q48468708 | Effect of the BDNF V166M polymorphism on working memory in healthy adolescents |
| Q43284373 | Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia |
| Q60907438 | Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism |
| Q57316782 | Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia |
| Q33723741 | Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder |
| Q30491898 | Efficient copackaging and cotransport yields postsynaptic colocalization of neuromodulators associated with synaptic plasticity |
| Q43245777 | Emotional distress in parents of psychotic patients is modified by serotonin transporter gene (5-HTTLPR)--brain-derived neurotrophic factor gene interactions. |
| Q38039966 | Endophenotypes as a measure of suicidality |
| Q36279126 | Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression |
| Q61447842 | Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression |
| Q39863109 | Essential role of Hrs in endocytic recycling of full-length TrkB receptor but not its isoform TrkB.T1. |
| Q39412337 | Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms |
| Q30490427 | Ethanol-BDNF interactions: still more questions than answers. |
| Q37123304 | Evidence of association between brain-derived neurotrophic factor gene and bipolar disorder |
| Q26991898 | Exercise, neurotrophins, and axon regeneration in the PNS |
| Q34134231 | Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding |
| Q36074354 | Fear extinction and BDNF: translating animal models of PTSD to the clinic |
| Q36327926 | Functional polymorphisms in dopamine and serotonin pathway genes |
| Q92491415 | Future considerations for pediatric cancer survivorship: Translational perspectives from developmental neuroscience |
| Q36668325 | GABAergic control of depression-related brain states |
| Q30462711 | GDNF and BDNF gene interplay in chronic tinnitus |
| Q35877933 | Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use |
| Q48401183 | Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies |
| Q34497567 | Gender-specific association of the brain-derived neurotrophic factor gene with attention-deficit/hyperactivity disorder |
| Q59807422 | Genetic Variants of the Brain-Derived Neurotrophic Factor and Metabolic Indices in Veterans With Posttraumatic Stress Disorder |
| Q34704748 | Genetic and behavioral determinants of hippocampal volume recovery during abstinence from alcohol. |
| Q36947139 | Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms |
| Q36328154 | Genetic modulation of BDNF signaling affects the outcome of axonal competition in vivo |
| Q38755102 | Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature |
| Q24679793 | Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior |
| Q35840890 | Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression |
| Q47835465 | Genetic variants in 5-HTTLPR, BDNF, HTR1A, COMT, and FKBP5 and risk for treated depression after cancer diagnosis |
| Q37004788 | Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease |
| Q34627311 | Genetic variation at the BDNF locus: evidence for association with long-term outcome after ischemic stroke |
| Q30417488 | Genetic variation in brain-derived neurotrophic factor and human fear conditioning |
| Q37088174 | Genetics as a molecular window into recovery, its treatment, and stress responses after stroke |
| Q34139876 | Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence |
| Q42413380 | Genotyping the BDNF rs6265 (val66met) polymorphism by one-step amplified refractory mutation system PCR. |
| Q51833459 | Glatiramer acetate (GA, Copolymer-1) an hypothetical treatment option for Rett syndrome |
| Q39144437 | Growth factors and hormones pro-peptides: the unexpected adventures of the BDNF prodomain. |
| Q37118169 | HIV-1 decreases the levels of neurotrophins in human lymphocytes |
| Q47602590 | Harsh Parenting and Serotonin Transporter and BDNF Val66Met Polymorphisms as Predictors of Adolescent Depressive Symptoms. |
| Q37708292 | High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons. |
| Q30478015 | Hippocampal neurons recycle BDNF for activity-dependent secretion and LTP maintenance. |
| Q46301222 | Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution |
| Q96131640 | Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities |
| Q28569078 | Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release |
| Q36700576 | Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene |
| Q28538189 | Identification of BDNF sensitive electrophysiological markers of synaptic activity and their structural correlates in healthy subjects using a genetic approach utilizing the functional BDNF Val66Met polymorphism |
| Q24644115 | Identification of pro- and mature brain-derived neurotrophic factor in human saliva |
| Q56768819 | Imaging genetics paradigms in depression research: Systematic review and meta-analysis |
| Q47871481 | Immediate-Early Genes Modulation by Antipsychotics: Translational Implications for a Putative Gateway to Drug-Induced Long-Term Brain Changes. |
| Q48105544 | Immunolocalization of pro- and mature-brain derived neurotrophic factor (BDNF) and receptor TrkB in the human brainstem and hippocampus |
| Q48315602 | Impact of BDNF -196 G>A and BDNF -270 C>T polymorphisms on stroke rehabilitation outcome: sex and age differences. |
| Q36845697 | Impact of BDNF Val66Met and 5-HTTLPR polymorphism variants on neural substrates related to sadness and executive function. |
| Q48189916 | Impact of BDNF Val66Met polymorphism on olfactory functions of female concussed athletes |
| Q37170569 | Impact of genetic variant BDNF (Val66Met) on brain structure and function |
| Q30460375 | Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics |
| Q36981190 | Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla |
| Q47248581 | Impaired cognitive flexibility during sleep deprivation among carriers of the Brain Derived Neurotrophic Factor (BDNF) Val66Met allele |
| Q64103534 | In silico analysis of the V66M variant of human BDNF in psychiatric disorders: An approach to precision medicine |
| Q37072952 | Influence of BDNF polymorphisms on Wilson's disease susceptibility and clinical course |
| Q35058421 | Influence of brain-derived neurotrophic factor and apolipoprotein E genetic variants on hemispheric and lateral ventricular volume of young healthy adults |
| Q33653447 | Interaction between 5-HTTLPR and BDNF Val66Met polymorphisms on HPA axis reactivity in preschoolers |
| Q46990510 | Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. |
| Q48225401 | Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. |
| Q48451564 | Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia |
| Q36288923 | Interaction between the BDNF gene Val/66/Met polymorphism and morning cortisol levels as a predictor of depression in adult women |
| Q48812755 | Interaction of COMT rs4680 and BDNF rs6265 polymorphisms on functional connectivity density of the left frontal eye field in healthy young adults |
| Q59791825 | Interactions of Val66Met Polymorphism and Menstrual Pain on Brain Complexity |
| Q35236607 | Intermediate phenotypes in schizophrenia: a selective review. |
| Q26781504 | Interrelation between Neuroendocrine Disturbances and Medical Complications Encountered during Rehabilitation after TBI |
| Q51819405 | Intracellular trafficking and secretion of cerebral dopamine neurotrophic factor in neurosecretory cells. |
| Q45796300 | Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine |
| Q44264783 | Involvement of BDNF signaling transmission from basolateral amygdala to infralimbic prefrontal cortex in conditioned taste aversion extinction. |
| Q37156921 | Involvement of brain-derived neurotrophic factor in late-life depression |
| Q38674655 | Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis |
| Q26828564 | Ketamine, sleep, and depression: current status and new questions |
| Q47615913 | Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood. |
| Q35929042 | Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory |
| Q41050624 | Loneliness in Relation to Depression: The Moderating Influence of a Polymorphism of the Brain Derived Neurotrophic Factor Gene on Self-efficacy and Coping Strategies |
| Q47271759 | Loss of Neuroprotective Factors in Neurodegenerative Dementias: The End or the Starting Point? |
| Q36749816 | Low-Level Stress Induces Production of Neuroprotective Factors in Wild-Type but Not BDNF+/- Mice: Interleukin-10 and Kynurenic Acid |
| Q37509863 | Measurement of the levels of leptin, BDNF associated with polymorphisms LEP G2548A, LEPR Gln223Arg and BDNF Val66Met in Thai with metabolic syndrome |
| Q38784077 | Mechanisms of the placebo effect in pain and psychiatric disorders |
| Q40036871 | Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity |
| Q40390647 | Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder. |
| Q37460218 | Modulation of dendritic spine development and plasticity by BDNF and vesicular trafficking: fundamental roles in neurodevelopmental disorders associated with mental retardation and autism |
| Q37776087 | Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease |
| Q26766487 | Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric Disorders |
| Q38904980 | Molecular mechanisms underlying alcohol-drinking behaviours |
| Q48852306 | Morphological properties of the action-observation cortical network in adolescents with low and high resistance to peer influence |
| Q38020487 | Multiple approaches to investigate the transport and activity-dependent release of BDNF and their application in neurogenetic disorders |
| Q40199654 | Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism. |
| Q90316534 | N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures |
| Q33708741 | Neurobiology of local and intercellular BDNF signaling |
| Q38435480 | Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. |
| Q46946716 | Neurophysiological and genetic distinctions between pure and comorbid anxiety disorders |
| Q37781350 | Neuroplasticity - exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. |
| Q36983344 | Neurotrophic factor control of satiety and body weight |
| Q38999345 | Neurotrophin Signaling and Stem Cells-Implications for Neurodegenerative Diseases and Stem Cell Therapy |
| Q38068714 | Neurotrophin regulation of neural circuit development and function |
| Q36011413 | Neurotrophin-mediated rapid signaling in the central nervous system: mechanisms and functions |
| Q39183381 | Neurotrophins and Proneurotrophins |
| Q36697163 | No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population |
| Q37049608 | No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis |
| Q38403023 | On the Run for Hippocampal Plasticity |
| Q48576876 | Overexpression of plasminogen activators in the nucleus accumbens enhances cocaine-, amphetamine- and morphine-induced reward and behavioral sensitization |
| Q34015158 | Paradoxical visuomotor adaptation to reversed visual input is predicted by BDNF Val66Met polymorphism |
| Q33695338 | Parental brain-derived neurotrophic factor genotype, child prosociality, and their interaction as predictors of parents' warmth |
| Q35752084 | Pathways Mediating Activity-Induced Enhancement of Recovery From Peripheral Nerve Injury |
| Q51829038 | Performance-related increases in hippocampal N-acetylaspartate (NAA) induced by spatial navigation training are restricted to BDNF Val homozygotes. |
| Q46903587 | Peripheral levels of BDNF and NGF in primary headaches |
| Q52146500 | Peripheral vascular reactivity and serum BDNF responses to aerobic training are impaired by the BDNF Val66Met polymorphism. |
| Q38103882 | Pharmacogenetic considerations for late life depression therapy |
| Q46852529 | Pharmacogenetics of neural injury recovery |
| Q37969219 | Pharmacogenetics of obsessive-compulsive disorders |
| Q30454454 | Physical exercise during encoding improves vocabulary learning in young female adults: a neuroendocrinological study |
| Q45777016 | Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease. |
| Q37184490 | Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers |
| Q33926241 | Population genetic study of the brain-derived neurotrophic factor (BDNF) gene |
| Q31035766 | Postpartum depressive symptoms and the BDNF Val66Met functional polymorphism: effect of season of delivery. |
| Q28573496 | Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing |
| Q36063778 | Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment. |
| Q93379630 | Prefrontal cortical trkB, glucocorticoids, and their interactions in stress and developmental contexts |
| Q36578272 | Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI. |
| Q90695436 | Prenatal intimate partner violence exposure predicts infant biobehavioral regulation: Moderation by the brain-derived neurotrophic factor (BDNF) gene |
| Q21132321 | Preservation of general intelligence following traumatic brain injury: contributions of the Met66 brain-derived neurotrophic factor |
| Q37051564 | Preventing the Return of Fear Using Reconsolidation Update Mechanisms Depends on the Met-Allele of the Brain Derived Neurotrophic Factor Val66Met Polymorphism. |
| Q40414334 | ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. |
| Q38125896 | Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor |
| Q48091762 | Proportional recovery after stroke depends on corticomotor integrity |
| Q38776707 | Protection of Cultured Dopamine Neurons from MPP(+) Requires a Combination of Neurotrophic Factors |
| Q38187948 | Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets |
| Q37076456 | Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction |
| Q24614410 | Rapid antidepressant effects: moving right along |
| Q41949286 | Reduced severity of posttraumatic stress disorder associated with Val allele of Val66Met polymorphism at brain-derived neurotrophic factor gene among Chinese adolescents after Wenchuan earthquake |
| Q30498250 | Region-specific involvement of BDNF secretion and synthesis in conditioned taste aversion memory formation |
| Q37225360 | Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway |
| Q58721314 | Relevance of polymorphisms in MC4R and BDNF in short normal stature |
| Q93138938 | Role of BDNF in the development of an OFC-amygdala circuit regulating sociability in mouse and human |
| Q90324876 | Role of a VGF/BDNF/TrkB Autoregulatory Feedback Loop in Rapid-Acting Antidepressant Efficacy |
| Q37024497 | Role of the brain-derived neurotrophic factor at glutamatergic synapses. |
| Q46952807 | Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury |
| Q34024804 | SNP rs6265 regulates protein phosphorylation and osteoblast differentiation and influences BMD in humans |
| Q48207060 | Screening for genetic variants in BDNF that contribute to childhood obesity |
| Q61810732 | Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients |
| Q92243847 | Serbian Twin Registry |
| Q51286658 | Serum Brain-Derived Neurotrophic Factor Mediates the Relationship between Abdominal Adiposity and Executive Function in Middle Age. |
| Q37213551 | Shaping neurons: Long and short range effects of mature and proBDNF signalling upon neuronal structure |
| Q37923872 | Signaling pathways mediating alcohol effects. |
| Q55001611 | Significant association of BDNF rs6265 G>A polymorphism with susceptibility to epilepsy: a meta-analysis. |
| Q24532072 | Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. |
| Q35842258 | Sorting protein-related receptor SorLA controls regulated secretion of glial cell line-derived neurotrophic factor |
| Q51873814 | Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity. |
| Q38728935 | Subthalamic Nucleus Deep Brain Stimulation Employs trkB Signaling for Neuroprotection and Functional Restoration. |
| Q38831859 | Synaptic alterations associated with depression and schizophrenia: potential as a therapeutic target |
| Q55133068 | Targeting the intracellular signaling "STOP" and "GO" pathways for the treatment of alcohol use disorders. |
| Q48244608 | The BDNF Val(66)Met polymorphism is associated with escitalopram response in depressed patients |
| Q90693896 | The BDNF Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review |
| Q89128873 | The BDNF Val66Met Prodomain Disassembles Dendritic Spines Altering Fear Extinction Circuitry and Behavior |
| Q41223158 | The BDNF Val66Met variant affects gene expression through miR-146b |
| Q41554744 | The BDNF Valine 68 to Methionine Polymorphism Increases Compulsive Alcohol Drinking in Mice That Is Reversed by Tropomyosin Receptor Kinase B Activation. |
| Q91666508 | The BDNF gene val66met polymorphism and behavioral inhibition in early childhood |
| Q40999723 | The BDNF val-66-met Polymorphism Affects Neuronal Morphology and Synaptic Transmission in Cultured Hippocampal Neurons from Rett Syndrome Mice. |
| Q53692090 | The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives. |
| Q35638019 | The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. |
| Q90351901 | The Moderating Role of COMT and BDNF Polymorphisms on Transfer Effects Following Multi- and Single-Domain Cognitive Training Among Community-Dwelling Shanghainese Older Adults |
| Q38263681 | The Physiology of BDNF and Its Relationship with ADHD. |
| Q61449132 | The Role of BDNF in Peripheral Nerve Regeneration: Activity-Dependent Treatments and Val66Met |
| Q28074012 | The Role of BDNF in the Development of Fear Learning |
| Q47140989 | The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies |
| Q35959765 | The brain-derived neurotrophic factor (BDNF) val66met polymorphism differentially affects performance on subscales of the Wechsler Memory Scale - Third Edition (WMS-III). |
| Q33833981 | The brain-derived neurotrophic factor Val66Met polymorphism affects encoding of object locations during active navigation. |
| Q48667441 | The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills |
| Q51935722 | The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. |
| Q36547467 | The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis |
| Q24650396 | The common BDNF polymorphism may be a modifier of disease severity in Rett syndrome |
| Q37952822 | The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. |
| Q28259199 | The impact of genetic research on our understanding of normal cognitive ageing: 1995 to 2009 |
| Q48216757 | The influence of high intensity exercise and the Val66Met polymorphism on circulating BDNF and locomotor learning |
| Q35576180 | The influences of diet and exercise on mental health through hormesis |
| Q48561637 | The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder |
| Q93079659 | The interplay of polygenic plasticity and adrenocortical activity as sources of variability in pathways among family adversity, youth emotional reactivity, and psychological problems |
| Q35801796 | The lighter side of BDNF. |
| Q21195685 | The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice |
| Q24649251 | The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism |
| Q36818579 | The presence of a single-nucleotide polymorphism in the BDNF gene affects the rate of locomotor adaptation after stroke |
| Q52685713 | The relationship between BDNF Val66Met polymorphism and functional mobility in chronic stroke survivors. |
| Q37344077 | The requirement of BDNF for hippocampal synaptic plasticity is experience-dependent |
| Q37729843 | The role of BDNF in depression on the basis of its location in the neural circuitry |
| Q90738818 | The role of BDNF methylation and Val66 Met in amygdala reactivity during emotion processing |
| Q35871363 | The role of brain-derived neurotrophic factor genotype, parental depression, and relationship discord in predicting early-emerging negative emotionality |
| Q47267712 | The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. |
| Q91938787 | The role of genetics in cognitive remediation in schizophrenia: A systematic review |
| Q35369290 | The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury |
| Q34897934 | The role of the brain-derived neurotrophic factor genotype and parenting in early life in predicting externalizing and internalizing symptoms in children with attention-deficit hyperactivity disorder |
| Q37139503 | The serotonin transporter linked polymorphic region and brain-derived neurotrophic factor valine to methionine at position 66 polymorphisms and maternal history of depression: associations with cognitive vulnerability to depression in childhood |
| Q37274645 | The skinny on brain-derived neurotrophic factor: evidence from animal models to GWAS. |
| Q34439423 | The yin and yang of neurotrophin action |
| Q34383112 | Toward a unified biological hypothesis for the BDNF Val66Met-associated memory deficits in humans: a model of impaired dendritic mRNA trafficking. |
| Q38484760 | Transcriptome profiling analysis of the mechanisms underlying the BDNF Val66Met polymorphism induced dysfunctions of the central nervous system |
| Q46654662 | Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. |
| Q58586784 | Val66Met Polymorphism and Gamma Band Disruption in Resting State Brain Functional Connectivity: A Magnetoencephalography Study in Cognitively Intact Older Females |
| Q48874582 | Val66Met polymorphism and serum brain-derived neurotrophic factor concentration in depressed patients |
| Q37287082 | Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction |
| Q37717633 | Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans |
| Q33997931 | Variant BDNF (Val66Met) impact on brain structure and function |
| Q35870094 | Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants |
| Q35009192 | Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI. |
| Q26864720 | Virogenetic and optogenetic mechanisms to define potential therapeutic targets in psychiatric disorders |
| Q36358072 | What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development |
| Q59340509 | proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing |
| Q61819760 | ‘Two Hit’ Neurodevelopmental Mechanisms in Schizophrenia: Focus on Animal Models and the Role of BDNF |
Search more.